Derivation of Tumor Specific Hybridomas

NCT01702792 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Investigator is leaving Dartmouth

Conditions

Glioblastoma

Interventions

BIOLOGICAL: Tumor Vaccine

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]